TRACON slumps 18% on $10M capital raise
- TRACON Pharmaceuticals (NASDAQ:TCON) enters into an underwriting agreement with H.C. Wainwright & Co. to purchase on a firm commitment basis 2,617,802 shares at a public offering price of $3.82 per share.
- Gross proceeds of ~$10M
- Offering is expected to close…
